TME Pharma N.V.

ALTME.PA | EURONEXT | 0 Sledující

€0.11

5.62%

€0.0058

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 EUR	12/31/2023 EUR	12/31/2022 EUR	12/31/2021 EUR
Total revenue	0 -100.00%	17 -	0 -100.00%	0 -
Cost of revenue	0 -100.00%	144 +56.52%	92 +39.39%	66 -
Gross profit	0 +100.00%	-127 -38.04%	-92 -39.46%	-66 -
Operating expense	5,277 -4.00%	5,497 -54.18%	11,996 -10.82%	13,451 -
Operating income	-5,277 +6.17%	-5,624 +53.25%	-12,029 +9.33%	-13,267 -
Pretax Income	0 +100.00%	-6,734 +55.48%	-15,126 -4.66%	-14,452 -
Tax Provision	0 -100.00%	2 -71.43%	7 +600.00%	1 -
Net income	-5,722 +15.05%	-6,736 +55.49%	-15,132 -4.71%	-14,452 -
EPS	-0.06 +95.46%	-1.34 +88.51%	-11.66 +41.26%	-19.85 -
Diluted EPS	-0.06 +95.46%	-1.34 +88.51%	-11.66 +41.26%	-19.85 -
Average Shares	0 -100.00%	5,019 +286.71%	1,298 +78.28%	728 -
Diluted Average Shares	0 -100.00%	5,019 +286.71%	1,298 +78.28%	728 -
EBIT	-5,245 -0.56%	-5,216 +55.52%	-11,726 +9.44%	-12,948 -
EBITDA	-5,245 -3.41%	-5,072 +56.40%	-11,634 +9.69%	-12,882 -

Soubory cookie používáme ke zlepšení prohlížení na webu.